3 hasil untuk "Gary T. Ferguson"

Goals of COPD treatment: Focus on symptoms and exacerbations

Claus Franz Vogelmeier; Miguel Román-Rodríguez; Dave Singh dkk.

Respiratory Medicine · 2020 · Inggris · OpenAlex Scopus

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study

Fernando J. Martínez; Klaus Friedrich Rabe; Gary T. Ferguson dkk.

American Journal of Respiratory and Critical Care Medicine · 2020 · Inggris · OpenAlex Scopus

Abstract Rationale In the phase III, 52-week ETHOS (Efficacy and Safety of Triple Therapy in Obstructive Lung Disease) trial in chronic obstructive pulmonary disease (COPD) (NCT02465567), triple therapy with budesonide/glycopyrrolate/formoterol fumarate (BGF) significantly reduced all-cause…

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

Klaus Friedrich Rabe; Fernando J. Martinez; Gary T. Ferguson dkk.

New England Journal of Medicine · 2020 · Inggris · OpenAlex Scopus

BACKGROUND: -agonist (LABA) for chronic obstructive pulmonary disease (COPD) have been studied at single dose levels of inhaled glucocorticoid, but studies at two dose levels are lacking. METHODS: In a 52-week, phase 3, randomized trial to evaluate the efficacy and safety of triple therapy at two…